Egypt to take part in coronavirus clinical trial testing Gilead’s remdesivir
Egypt will take part in the clinical trial testing for remdesivir as a potential treatment for the coronavirus,…
Remdesivir helped moderate coronavirus patients improve: Gilead
Gilead Sciences Inc said that its antiviral drug remdesivir showed improvement in patients with moderate COVID-19…
Egypt joins WHO global initiative to openly share research to fight coronavirus
Egypt has on Friday signed up the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), a…
European stocks advance on global vaccine hopes; Travel stocks surge 6.4%
European stocks advanced on Tuesday, tracking positive global market sentiment as optimism grows that a coronavirus…
U.S. pledges $1.2 billion to accelerate Oxford University vaccine, secure 300 million…
The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s experimental…
World Bank: Coronavirus pandemic could push 60 million people into extreme poverty
The coronavirus pandemic and the resulting economic shutdown could push 60 million people around the world into…
European markets rebound as investors monitor vaccine, recovery prospects
European stocks rebounded from early losses on Wednesday as cautiously positive global market sentiment returned.
Naguib Sawiris: more coronavirus shutdowns will make 2021 another challenging year for…
Egyptian billionaire Naguib Sawiris said on Tuesday that extending coronavirus shutdowns will mean that half the…
China’s Xi pledges $2 billion to help fight coronavirus
Chinese President Xi Jinping said that his country will provide $2 billion over two years to help other countries…
Dow futures turn negative a day after stocks surge on vaccine hopes
Stock futures turned slightly lower in early trading Tuesday after the market scored its best session in six weeks…
